Company: APACU
Filing Date: 2025-08-01
Form Type: S-1/A
Source: 0001829126-25-005702
Chunk: 257

Company: StoneBridge Acquisition II Corp
Filing Date: 2025-08-01
Form: S-1/A
Chunk 257
---
 for no consideration after the closing of this offering depending on the extent to which the underwriter’s over-allotment option is exercised, (ii) the Maxim individuals collectively currently own 215,000 founder shares purchased for approximately $0.013 per share and (iii) the third-party investors collectively currently own 610,000 founder shares purchased for approximately $0.013 per share.

The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 5,750,000 units if the underwriter’s over-allotment option is exercised in full, and therefore that such founder shares would represent 25% of the outstanding shares after this offering. Up to 250,000 of the founder shares held by our sponsor will be surrendered for no consideration depending on the extent to which the underwriter’s over-allotment is exercised. If we increase or decrease the size of the offering, we will effect a share capitalization or a share repurchase or redemption or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares, on an as-converted basis, at 25% of our issued and outstanding ordinary shares upon the consummation of this offering.

Our sponsor, the Maxim Individuals and the third-party investors have agreed to purchase an aggregate of 150,000 units (or 153,750 units if the underwriter’s over-allotment option is exercised in full), at a price of $10.00 per unit, for an aggregate purchase price of $1,500,000 (or $1,537,500 if the underwriter’s over-allotment option is exercised in full), in a private placement that will close simultaneously with the closing of this offering. Of such 150,000 units (or 153,750 units if the underwriter’s over-allotment option is exercised in full), 65,000 units (or 68,750 units if the underwriter’s over-allotment option is exercised in full) will be purchased by our sponsor, 22,152 units will be purchased by the Maxim Individuals, and 62,848 units will be purchased by the third-party investors. We refer to these units as the “private placement units.” Each private placement unit will be identical to the units sold in this offering, except that, so long as they are held by our initial shareholders or their permitted transfere